Matthew Onaitis
2016
In 2016, Matthew Onaitis earned a total compensation of $1.1M as Chief Financial Officer, General Counsel, and Secretary at Cidara Therapeutics.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $57,758 |
| Option Awards | $798,479 |
| Salary | $162,500 |
| Other | $19,468 |
| Total | $1,063,205 |
Onaitis received $798.5K in option awards, accounting for 75% of the total pay in 2016.
Onaitis also received $25K in bonus, $57.8K in non-equity incentive plan, $162.5K in salary and $19.5K in other compensation.
Rankings
In 2016, Matthew Onaitis' compensation ranked 7,949th out of 14,075 executives tracked by ExecPay. In other words, Onaitis earned more than 43.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,949 out of 14,075 | 44th |
Division Manufacturing | 3,027 out of 5,489 | 45th |
Major group Chemicals And Allied Products | 1,005 out of 1,895 | 47th |
Industry group Drugs | 778 out of 1,538 | 49th |
Industry Biological Products, Except Diagnostic Substances | 139 out of 279 | 50th |
Source: SEC filing on April 28, 2017.
Onaitis' colleagues
We found three more compensation records of executives who worked with Matthew Onaitis at Cidara Therapeutics in 2016.